Search Results - Hospital-Gustem, Carole

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center

    Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center by Sesques, Pierre, Ferrant, Emmanuelle, Safar, Violaine, Wallet, Florent, Tordo, Jérémie, Dhomps, Anthony, Karlin, Lionel, Brisou, Gabriel, Vercasson, Marlène, Hospital‐Gustem, Carole, Schwiertz, Vérane, Ranchon, Florence, Rioufol, Catherine, Choquet, Marion, Sujobert, Pierre, Ghergus, Dana, Bouafia, Fadhela, Golfier, Camille, Lequeu, Helène, Lazareth, Anne, Novelli, Silvana, Devic, Perrine, Traverse Glehen, Alexandra, Viel, Sébastien, Venet, Fabienne, Mialou, Valérie, Hequet, Olivier, Chauchet, Adrien, Arkam, Yazid, Nicolas‐Virelizier, Emmanuelle, Peyrade, Frederic, Cavalieri, Doriane, Ader, Florence, Ghesquières, Hervé, Salles, Gilles, Bachy, Emmanuel

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells

    Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells by Sesques, Pierre, Tordo, Jérémie, Ferrant, Emmanuelle, Safar, Violaine, Wallet, Florent, Dhomps, Anthony, Brisou, Gabriel, Bouafia, Fadhela, Karlin, Lionel, Ghergus, Dana, Golfier, Camille, Lequeu, Helène, Lazareth, Anne, Vercasson, Marlène, Hospital-Gustem, Carole, Schwiertz, Vérane, Choquet, Marion, Sujobert, Pierre, Novelli, Silvana, Mialou, Valérie, Hequet, Olivier, Carras, Sylvain, Fouillet, Ludovic, Lebras, Laure, Guillermin, Yann, Leyronnas, Cécile, Cavalieri, Doriane, Janier, Marc, Ghesquières, Hervé, Salles, Gilles, Bachy, Emmanuel

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells

    Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells by Sesques, Pierre, Tordo, Jérémie, Ferrant, Emmanuelle, Safar, Violaine, Wallet, Florent, Dhomps, Anthony, Brisou, Gabriel, Bouafia, Fadhela, Karlin, Lionel, Ghergus, Dana, Golfier, Camille, Lequeu, Helène, Lazareth, Anne, Vercasson, Marlène, Hospital-Gustem, Carole, Schwiertz, Vérane, Choquet, Marion, Sujobert, Pierre, Novelli, Silvana, Mialou, Valérie, Hequet, Olivier, Carras, Sylvain, Fouillet, Ludovic, Lebras, Laure, Guillermin, Yann, Leyronnas, Cécile, Cavalieri, Doriane, Janier, Marc, Ghesquières, Hervé, Salles, Gilles, Bachy, Emmanuel

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: